Data management

Yseop's impactful Generative AI capabilities helping accelerate drugs to market

07-Dec-2023 By Liza Laws

Today, world-leading generative artificial intelligence (AI) company for life sciences, Yseop, is celebrating its involvement in more than 150 clinical trials with pharma giants around the world.

Symbiosis Pharmaceutical Services granted MHRA license following £1 million investment

07-Dec-2023 By Liza Laws

Symbiosis Pharmaceutical Services can now test small molecule, biological and advanced therapeutical medicinal products (ATMP) following a £1 million investment.

ObvioHealth reveals new digital therapeutics API to capture more accurate clinical data

07-Dec-2023 By Liza Laws

Virtual research organization, ObvioHealth, has just announced the launch of its application programming interface (API) which it says is tailored specifically for digital therapeutics (DTx) clinical trials.

SSNL Manufacturing updates

Q&A: Univar Solutions - the importance and challenges of distributing and sourcing pharma ingredients

06-Dec-2023 By Liza Laws

From its origins in ancient military time where the Romans and Greeks used logistics and distribution channels to supply their armies, to today's challenges with the supply chain for pharma ingredients, we enjoyed putting some questions to Univar...

Calliditas' hope to provide treatment for Alport syndrome boosted by studies

05-Dec-2023 By Liza Laws

A phase 2 study looking into the treatment setanaxib for inherited kidney disease, Alport syndrome, has begun it was announced last week.

Six company cohort joins BII's new accelerator start-up program to unlock potential of quantum science

01-Dec-2023 By Liza Laws

The first six companies enter the Deep Tech Lab - Quantum start-up accelerator at BioInnovation Institute (BII) to unlock the potential in quantum science

England's vision for an end to new cases of HIV by 2030 is on track after positive trial results

30-Nov-2023 By Liza Laws

Using a combination of pre-existing HIV drugs, a medicine for HIV-negative people taken before sex has reduced the chances of getting the virus by 86%.

Not to be missed - our patient centricity in action webinar with three top speakers

28-Nov-2023 By Liza Laws

Outsourcing Pharma is delighted to invite you to join our not-to-be-missed webinar on one of the most important areas of the industry – patient centricity – and its solutions.

Call for volunteers to test ground-breaking psychedelic treatments for mental health conditions

28-Nov-2023 By Liza Laws

Volunteers with conditions including depression, alcohol use disorder, and anorexia are being sought by Clerkenwell Health, to join its seminal clinical trials.

Legalized medical cannabis five years on - Releaf reveals impact of negative stigma and lack of legal knowledge

27-Nov-2023 By Liza Laws

It is five years this month since a ground-breaking change in UK healthcare history happened – with doctors being able to prescribe cannabis-based medicines for the first time.

Flywheel and Microsoft collaborate to unlock powerful data insights in medical imaging

23-Nov-2023 By Liza Laws

Healthcare breakthroughs have long-standing barriers when it comes to unlocking the powerful insights trapped in medical imaging data.

CluePoints wins prestigious accolade for commitment to innovation and education

21-Nov-2023 By Liza Laws

CluePoints, a company providing risk-based study execution (RBx) and risk-based quality management (RBQM) software for clinical trials has won the best Contract Research Organization (CRO) in the specialist providers category at Citeline’s 2023 SCRIP...

More focus on precision medicine than ever before and what makes iSpecimen different

21-Nov-2023 By Liza Laws

OSP had a discussion with Tracy Curley, CEO of iSpecimen, and Eric Langlois, chief revenue officer of iSpecimen and Michael Howell,founder of Mountaineer Biosciences, Inc. to discuss a number of issues those working in precision medicine still face.

Greenphire and Florence Healthcare join forces to improve study collaborations

21-Nov-2023 By Liza Laws

Greenphire has announced a technology partnership that integrates two of the most popular software solutions in the industry.

Interview: CRO PPD of Thermo Fisher - the processes and difficulties within rare diseases

17-Nov-2023 By Liza Laws

OSP was delighted to speak to Galina Nesterova, executive medical director at the Rare Disease & Pediatrics Center of Excellence, and Susan McCune, vice president of pediatrics and clinical pharmacology both within medical science and strategy at...

Dpharm Deep Dive: Speeding up access to clinical data and how picking EDETEK was a good choice for Pfizer

17-Nov-2023 By Liza Laws

EDETEK and Pfizer are in collaboration to speed access to clinical data, promote interoperability and enable data visualization to drive faster decision-making capabilities in clinical operations.

Not-for-profit alliance advocates for life sciences collaboration

16-Nov-2023 By Liza Laws

The Pistoia Alliance is a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D. It has just announced its four new strategic priorities made up of global pharma and tech representatives to deliver new project...

Interview: Phenomix' Mark Bagnall and obesity's four different phenotypes

13-Nov-2023 By Liza Laws

Ever since injections promising to help people lose weight hit the shelves, interest around the world has been phenomenal. So high was demand, companies were finding it difficult to keep up with the demand.

Sosei Heptares and Kallyope collaboration milestone with first GPCR target

10-Nov-2023 By Liza Laws

The first scientific milestone stemming from a collaboration between Sosei Heptares and Kallyope that was announced last year (2022) has been reached.

Interview: CEO Matt Walz and what's creating the buzz around Trialbee

08-Nov-2023 By Liza Laws

Matt Walz is CEO at Trialbee and has more than 20 years of software and leadership experience in the life sciences industry.

9Exchange partners with PhaseV to give its members new opportunities to progress unwanted drugs

07-Nov-2023 By Liza Laws

Israeli biopharma marketplace, 9Exchange, has partnered with PhaseV a causal machine learning (ML) company, it was announced yesterday (November 6).

Curavit capturing health economics evidence with new HEOR practice

06-Nov-2023 By Liza Laws

With rising healthcare costs and ‘less understood digital therapeutics’ Curavit has launched a health economics and outcomes research (HEOR) practice.

SSNL: Rare and Orphan digest

Rare disease clinical trials: The need for more patient- and site-centricity

01-Nov-2023 By Liza Laws

OSP had a quickfire interview with Rebecca Starkie, senior global patient engagement director, at Advanced Clinical where she explains the challenges faced by rare disease patients - and suggests ways to improve.

SSNL Rare and Orphan Digest

Element Biosciences to showcase its DNA sequencing platform 'disrupting the genomics industry'

01-Nov-2023 By Liza Laws

Element Biosciences, Inc., will share news of its sequencing methodology and host a workshop on higher accuracy sequencing for improved variant detection in Washington DC from today.

Women in Science: Kathryn Starzyk on the power and complexities of real-world evidence

01-Nov-2023 By Liza Laws

Kathryn Starzyk is an epidemiologist and currently vice president of real-world evidence (RWE) at healthcare technology company, OM1.

PicnicHealth acquires AllStripes platform to better engage patients

01-Nov-2023 By Liza Laws

PicnicHealth announced recently that it has acquired AllStripes, a platform generating evidence about the rare disease industry community.

CPHI 2023

Syniti launches bold 'data first' strategy for true paradigm shift in digital transformations

26-Oct-2023 By Liza Laws

A company that says they have never heard of clients starting their data work too soon has launched a ‘bold data first strategy’.

AxoSim's acquisition of microBrain to transform neurological R&D

24-Oct-2023 By Liza Laws

A company’s goal of delivering human data faster to ‘transform neurological R&D’ has been boosted by the completion of an acquisition.

Empatica and the importance of wearable devices in getting the full patient profile

20-Oct-2023 By Liza Laws

Matteo Lai was part of a panel at DPharm in Boston this year, it was called working together to accelerate the adoption of digital biomarkers in clinical trials.

Walgreens and Cardiovascular Research Foundation join forces to 'tackle critical health challenge'

19-Oct-2023 By Liza Laws

A collaboration has been formed between the US pharmacy chain Walgreens and the Cardiovascular Research Foundation (CRF) to measure how prevalent valvular heart disease (VHD) is among older Americans.

Interview: EDETEK's Munther Baara on the paradigm shift in clinical trials

12-Oct-2023 By Liza Laws

Munther Baara has worked in the life sciences arena for more than 30 years. He has always been completely committed.

CRF study smashes diversity targets in trials with three times national average

10-Oct-2023 By Liza Laws

Complete clinical trials solution company, Hawthorne Effect, announced today (October 10) it had successfully recruited more than 1,000 patients in 48 states plus Hawaii for a study to qualify the prevalence of valvular heart disease (VHD).

NCI and Medidata extend partnership by five years to support critical oncology research

09-Oct-2023 By Liza Laws

A 15-year partnership between Medidata, a Dassault Systèmes company, and the National Cancer Institute (NCI) has been extended by five years. The NCI is part of the National Institutes of Health.

DPHARM 2023

DPharm 2023 deep dive: IQVIA the important balance between the patient and technology

05-Oct-2023 By Liza Laws

At DPharm 2023, there was a huge meeting of minds to discuss the latest innovations in clinical trials. Outsourcing Pharma was delighted to have an in-depth discussion with IQVIA’s Elan Josielewski, senior principal and head of operations, patient centered...

Veradigm and Holmusk move closer to creating 'single source of truth' for behavioral health

03-Oct-2023 By Liza Laws

Veradigm Inc. and Holmusk have announced the next step in their strategic collaboration helping them move closer to their vision of creating a single source of truth for behavioral health.

Belong.Life launches Tara - an AI SaaS matching cancer patients to clinical trials

21-Sep-2023 By Liza Laws

Built upon seven years of real-world patient journey data, Belong.Life has recently announced the launch of its software as a service (SaaS)-based conversational artificial intelligence (AI) cancer clinical trial matching platform.

FDA clearance given to Beacon Biosignals' AI-assisted sleep monitoring device

19-Sep-2023 By Liza Laws

An advanced wearable headband with integrated machine learning algorithms has achieved The US Food and Drug Administration’s 510(k) clearance.

CymaBay's study of drug to help patients with persistent elevation of ALP has begun

05-Sep-2023 By Liza Laws

CymaBay announced recently the initiation of its 52-week, placebo-controlled, randomized, phase 3 study — 'Intended to Determine the Effects of seladelpar on normalization of Alkaline phosphatase (ALP) Levels in subjects with Primary Biliary Cholangitis...

Interview: Andrew MacGarvey COO of Phastar on opportunities for big analytical data

04-Sep-2023 By Liza Laws

Andrew MacGarvey is chief operating officer (COO) of Phastar. We caught up with him earlier in the summer at DIA Global in Boston to discuss the company’s origins, opportunities for big analytical data DCTs, artificial intelligence and machine learning...

Amit Etkin: the former Stanford professor pioneering a new treatment for depression

31-Aug-2023 By Isabel Cameron

More people are talking about mental illness than ever before. However, despite increased awareness, it remains one of the most neglected areas of public health globally, with research and quality of care lagging behind physical health conditions.

Exciting line-up and speakers for the 7th IPF Annual Summit in Boston next month

30-Aug-2023 By Liza Laws

With more than 63 biopharma companies attending and 15 event partners sharing solutions, the 7th Annual IPF Summit being held in Boston next month (September 2023) is not to be missed.

'Significant milestone' as STARLIMS acquires Labstep to unlock lab data's full potential

25-Aug-2023 By Liza Laws

STARLIMS, a company that provides enterprise informatics solutions has acquired Labstep, a research and development (R&D) electronic laboratory notebook (ELN).

Mahana Therapeutics and Bayer in multi-million dollar partnership to commercialize digital therapeutics

24-Aug-2023 By Liza Laws

Mahana Therapeutics announced last week (August 22) that it was entering into a multi-million dollar distribution and marketing partnership with the consumer health division of Bayer.

Oracle joins White House CancerX initiative to wage war on cancer

24-Aug-2023 By Liza Laws

Cloud services and life sciences company, Oracle, has been recognized as a founding member of The White House's public-private partnership CancerX.

DIA Global

Watch Yseop showcase Copilot 'the world's most secure automation solution'

23-Aug-2023 By Liza Laws

Another company OSP was lucky enough to catch up with at DIA Global in Boston this year, was well-established generative artificial intelligence (AI) software company, Yseop.

Lokavant interview: The company's expansion across real world data and why the industry needs to be wary of AI

17-Aug-2023 By Liza Laws

Rohit Nambisam is CEO of Lokavant, OSP caught up with him at DIA Global in Boston earlier this summer to find out more about him and the work he is passionate about.

Seed round of $2.25M secured for LighthouseAI's compliance product suite

14-Aug-2023 By Liza Laws

LighthouseAI, a company that specializes in compliance solutions for the pharmaceutical supply chain, has announced a $2.25 million seed round, led by Healthy Ventures with participation from Bertelsmann Next.

Interview: Phastar's Stephen Corson on his passion for stats and why they are so important for all health-related areas

07-Aug-2023 By Liza Laws

OSP was fortunate enough to have an interesting discussion with Stephen Corson, who is a statistics manager at Phastar, a specialist biometrics CRO headquartered in the UK.

CluePoints announces full agenda and speakers for free RBQM event next month

04-Aug-2023 By Liza Laws

Risk-based quality management (RBQM) is used to identify and assess risks then finding ways to manage them and is an important part of clincal trials.

Mural Health - giving power to the patients wanting to take part in clinical trials

11-Jul-2023 By Liza Laws

Jason Dong, co-CEO-founder of Mural Health, wants to make sure patients taking part in trials are not out of pocket. He joined OSP while at DIA Global to discuss how his business came about and why it is so important.